VCNX — Vaccinex Balance Sheet
0.000.00%
Last trade - 00:00- $1.78m
- $2.37m
- $0.60m
Annual balance sheet for Vaccinex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10.6 | 8.59 | 6.39 | 1.53 | 1.11 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.157 | 0 | 0.175 | 0.961 | 0.838 |
| Prepaid Expenses | |||||
| Total Current Assets | 11.3 | 9.4 | 7.48 | 3.35 | 2.53 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.416 | 0.438 | 0.499 | 0.282 | 0.065 |
| Total Assets | 11.7 | 9.84 | 7.98 | 3.63 | 2.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13.2 | 2.26 | 2.54 | 5.92 | 5.08 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 38.3 | 2.43 | 2.78 | 5.94 | 5.08 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | -26.6 | 7.41 | 5.19 | -2.31 | -2.49 |
| Total Liabilities & Shareholders' Equity | 11.7 | 9.84 | 7.98 | 3.63 | 2.6 |
| Total Common Shares Outstanding |